Practice alert – Early use of abemaciclib increases survival of breast cancer patients
A long-term study treating certain breast cancer patients with a CDK4/6i plus ET - an unmet need in early breast cancer treatment is being addressed
Learning objectives:
- To understand the unmet needs in treatment of HR+/HER2- breast cancer patients
- To understand current trial data supporting the need for early intervention
- To gain insights from current evidence regarding the efficacy and safety of abamaciclib treatment
To access this module, please register or login: